Patent Data for Comparative Study: Case study of Top Aspirants in Bioinformatics Industry

Authors

  • Neha Mago CSIR-Unit for Research and Development of Information Products (URDIP)
  • Nishad Deshpande CSIR-Unit for Research and Development of Information Products (URDIP)

DOI:

https://doi.org/10.5585/iji.v6i1.121

Keywords:

Patent, innovation, comparative advantage, company, bioinformatic, industry, computational

Abstract

Innovation and technology are considered as a subject of success and achievement to the firm. The comparative study represents an essential procedure to identify the innovation and technological capabilities of major players involved in the bioinformatics related inventions. The aim of the research is to map out the top firms and identify their strategically important technologies. In view of this, the comparative analysis of major firms in bioinformatics industry is carried out using patent information. Herein the top three assignees are considered and based on this further analysis is performed. The top companies’ trend suggests that Thermo Fisher Scientific Inc. is the major player in bioinformatics research. Thus, we have tried to develop an overview on their patenting trend and important concerned areas of research. Also, our results indicate that the application of computational tools is being utilized for most of the research areas like the study of genomics and proteomics, sequence categorization and their structural prediction.

Downloads

Download data is not yet available.

Downloads

Published

10.01.2018

How to Cite

Mago, N., & Deshpande, N. (2018). Patent Data for Comparative Study: Case study of Top Aspirants in Bioinformatics Industry. International Journal of Innovation, 6(1), 33–39. https://doi.org/10.5585/iji.v6i1.121

Issue

Vol. 6 No. 1 (2018): January/April

Section

Articles

License

Copyright (c) 2017 International Journal of Innovation (IJI Journal)

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Authors who publish with this journal agree to the following terms:

The author(s) authorize the publication of the article in the journal.

The author(s) ensure that the contribution is original and unpublished and is not being evaluated in other journal(s).

The journal is not responsible for the opinions, ideas and concepts expressed in the texts because they are the sole responsibility of the author(s).

The publishers reserve the right to make adjustments and textual adaptation to the norms of APA.

Authors retain copyright and grant the journal right of first publication, with the work after publication simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.

Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.

Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access) at http://opcit.eprints.org/oacitation-biblio.html

Authors  are able to use ORCID is a system of identification for authors. An ORCID identifier is unique to an individual and acts as a persistent digital identifier to ensure that authors (particularly those with relatively common names) can be distinguished and their work properly attributed.